Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Rakuten Medical Inc. has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 examiners and 2 art units, so at least one examination assignment carries more than one pending action.
PERREIRA, MELISSA JEAN is the listed busiest examiner, with 2 pending matters. Counsel should prioritize consistency across that examiner’s files while separately addressing the remaining assignment.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PERREIRA, MELISSA JEAN | 2 | 52.1% | +25.7% |
| BUTTICE, AUDREY L | 1 | 46.6% | +26.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17469804 | COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY | PERREIRA, MELISSA JEAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17477419 | COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY | PERREIRA, MELISSA JEAN | 58d overdue |
| 17782111 | METHODS FOR ENHANCING IMMUNITY AND TUMOR TREATMENT | BUTTICE, AUDREY L | — |
| 17469804 | COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY | PERREIRA, MELISSA JEAN | — |
| Art Unit | Apps |
|---|---|
| 1618 | 2 |
| 1647 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17782111 | METHODS FOR ENHANCING IMMUNITY AND TUMOR TREATMENT | BUTTICE, AUDREY L | 1647 | §103DP | Final Rejection | — | Pending | Jun 02, 2022 |
| 17477419 | COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY | PERREIRA, MELISSA JEAN | 1618 | §103Other | Final Rejection | 58d overdue | Pending | Sep 16, 2021 |
| 17469804 | COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY | PERREIRA, MELISSA JEAN | 1618 | §103§112 | Non-Final OA | — | Pending | Sep 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRakuten Medical Inc. has 3 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Melissa Jean Perreira has the most, with 2 of Rakuten Medical Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
